List of Chapters/Sections(Table Of Content)
1 Cancer Biopsy Instruments and Kits Market Overview
1.1 Product Overview and Scope of Cancer Biopsy Instruments and Kits
1.2 Cancer Biopsy Instruments and Kits Segment by Type
1.2.1 Global Cancer Biopsy Instruments and Kits Sales Growth Rate Comparison by Type (2022-2028)
1.2.2 Cancer Biopsy Instruments
1.2.3 Cancer Biopsy Kits
1.3 Cancer Biopsy Instruments and Kits Segment by Application
1.3.1 Global Cancer Biopsy Instruments and Kits Sales Comparison by Application: (2022-2028)
1.3.2 Breast Cancer
1.3.3 Colorectal Cancer
1.3.4 Cervical Cancer
1.3.5 Lung Cancer
1.3.6 Others
1.4 Global Cancer Biopsy Instruments and Kits Market Size Estimates and Forecasts
1.4.1 Global Cancer Biopsy Instruments and Kits Revenue 2017-2028
1.4.2 Global Cancer Biopsy Instruments and Kits Sales 2017-2028
1.4.3 Cancer Biopsy Instruments and Kits Market Size by Region: 2017 Versus 2021 Versus 2028
2 Cancer Biopsy Instruments and Kits Market Competition by Manufacturers
2.1 Global Cancer Biopsy Instruments and Kits Sales Market Share by Manufacturers (2017-2022)
2.2 Global Cancer Biopsy Instruments and Kits Revenue Market Share by Manufacturers (2017-2022)
2.3 Global Cancer Biopsy Instruments and Kits Average Price by Manufacturers (2017-2022)
2.4 Manufacturers Cancer Biopsy Instruments and Kits Manufacturing Sites, Area Served, Product Type
2.5 Cancer Biopsy Instruments and Kits Market Competitive Situation and Trends
2.5.1 Cancer Biopsy Instruments and Kits Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Cancer Biopsy Instruments and Kits Players Market Share by Revenue
2.5.3 Global Cancer Biopsy Instruments and Kits Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Cancer Biopsy Instruments and Kits Retrospective Market Scenario by Region
3.1 Global Cancer Biopsy Instruments and Kits Retrospective Market Scenario in Sales by Region: 2017-2022
3.2 Global Cancer Biopsy Instruments and Kits Retrospective Market Scenario in Revenue by Region: 2017-2022
3.3 North America Cancer Biopsy Instruments and Kits Market Facts & Figures by Country
3.3.1 North America Cancer Biopsy Instruments and Kits Sales by Country
3.3.2 North America Cancer Biopsy Instruments and Kits Revenue by Country
3.3.3 United States
3.3.4 Canada
3.4 Europe Cancer Biopsy Instruments and Kits Market Facts & Figures by Country
3.4.1 Europe Cancer Biopsy Instruments and Kits Sales by Country
3.4.2 Europe Cancer Biopsy Instruments and Kits Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Cancer Biopsy Instruments and Kits Market Facts & Figures by Region
3.5.1 Asia Pacific Cancer Biopsy Instruments and Kits Sales by Region
3.5.2 Asia Pacific Cancer Biopsy Instruments and Kits Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 China Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.6 Latin America Cancer Biopsy Instruments and Kits Market Facts & Figures by Country
3.6.1 Latin America Cancer Biopsy Instruments and Kits Sales by Country
3.6.2 Latin America Cancer Biopsy Instruments and Kits Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Cancer Biopsy Instruments and Kits Market Facts & Figures by Country
3.7.1 Middle East and Africa Cancer Biopsy Instruments and Kits Sales by Country
3.7.2 Middle East and Africa Cancer Biopsy Instruments and Kits Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Cancer Biopsy Instruments and Kits Historic Market Analysis by Type
4.1 Global Cancer Biopsy Instruments and Kits Sales Market Share by Type (2017-2022)
4.2 Global Cancer Biopsy Instruments and Kits Revenue Market Share by Type (2017-2022)
4.3 Global Cancer Biopsy Instruments and Kits Price by Type (2017-2022)
5 Global Cancer Biopsy Instruments and Kits Historic Market Analysis by Application
5.1 Global Cancer Biopsy Instruments and Kits Sales Market Share by Application (2017-2022)
5.2 Global Cancer Biopsy Instruments and Kits Revenue Market Share by Application (2017-2022)
5.3 Global Cancer Biopsy Instruments and Kits Price by Application (2017-2022)
6 Key Companies Profiled
6.1 QIAGEN NV
6.1.1 QIAGEN NV Corporation Information
6.1.2 QIAGEN NV Description and Business Overview
6.1.3 QIAGEN NV Cancer Biopsy Instruments and Kits Sales, Revenue and Gross Margin (2017-2022)
6.1.4 QIAGEN NV Cancer Biopsy Instruments and Kits Product Portfolio
6.1.5 QIAGEN NV Recent Developments/Updates
6.2 Illumina, Inc.
6.2.1 Illumina, Inc. Corporation Information
6.2.2 Illumina, Inc. Description and Business Overview
6.2.3 Illumina, Inc. Cancer Biopsy Instruments and Kits Sales, Revenue and Gross Margin (2017-2022)
6.2.4 Illumina, Inc. Cancer Biopsy Instruments and Kits Product Portfolio
6.2.5 Illumina, Inc. Recent Developments/Updates
6.3 Becton, Dickinson and Company
6.3.1 Becton, Dickinson and Company Corporation Information
6.3.2 Becton, Dickinson and Company Description and Business Overview
6.3.3 Becton, Dickinson and Company Cancer Biopsy Instruments and Kits Sales, Revenue and Gross Margin (2017-2022)
6.3.4 Becton, Dickinson and Company Cancer Biopsy Instruments and Kits Product Portfolio
6.3.5 Becton, Dickinson and Company Recent Developments/Updates
6.4 Myriad Genetics
6.4.1 Myriad Genetics Corporation Information
6.4.2 Myriad Genetics Description and Business Overview
6.4.3 Myriad Genetics Cancer Biopsy Instruments and Kits Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Myriad Genetics Cancer Biopsy Instruments and Kits Product Portfolio
6.4.5 Myriad Genetics Recent Developments/Updates
6.5 Thermo Fisher Scientific, Inc.
6.5.1 Thermo Fisher Scientific, Inc. Corporation Information
6.5.2 Thermo Fisher Scientific, Inc. Description and Business Overview
6.5.3 Thermo Fisher Scientific, Inc. Cancer Biopsy Instruments and Kits Sales, Revenue and Gross Margin (2017-2022)
6.5.4 Thermo Fisher Scientific, Inc. Cancer Biopsy Instruments and Kits Product Portfolio
6.5.5 Thermo Fisher Scientific, Inc. Recent Developments/Updates
6.6 BIOCEPT, INC.
6.6.1 BIOCEPT, INC. Corporation Information
6.6.2 BIOCEPT, INC. Description and Business Overview
6.6.3 BIOCEPT, INC. Cancer Biopsy Instruments and Kits Sales, Revenue and Gross Margin (2017-2022)
6.6.4 BIOCEPT, INC. Cancer Biopsy Instruments and Kits Product Portfolio
6.6.5 BIOCEPT, INC. Recent Developments/Updates
6.7 ANGLE plc
6.6.1 ANGLE plc Corporation Information
6.6.2 ANGLE plc Description and Business Overview
6.6.3 ANGLE plc Cancer Biopsy Instruments and Kits Sales, Revenue and Gross Margin (2017-2022)
6.4.4 ANGLE plc Cancer Biopsy Instruments and Kits Product Portfolio
6.7.5 ANGLE plc Recent Developments/Updates
6.8 Hologic, Inc.
6.8.1 Hologic, Inc. Corporation Information
6.8.2 Hologic, Inc. Description and Business Overview
6.8.3 Hologic, Inc. Cancer Biopsy Instruments and Kits Sales, Revenue and Gross Margin (2017-2022)
6.8.4 Hologic, Inc. Cancer Biopsy Instruments and Kits Product Portfolio
6.8.5 Hologic, Inc. Recent Developments/Updates
6.9 Lucence Diagnostics Pte. Ltd.
6.9.1 Lucence Diagnostics Pte. Ltd. Corporation Information
6.9.2 Lucence Diagnostics Pte. Ltd. Description and Business Overview
6.9.3 Lucence Diagnostics Pte. Ltd. Cancer Biopsy Instruments and Kits Sales, Revenue and Gross Margin (2017-2022)
6.9.4 Lucence Diagnostics Pte. Ltd. Cancer Biopsy Instruments and Kits Product Portfolio
6.9.5 Lucence Diagnostics Pte. Ltd. Recent Developments/Updates
6.10 Danaher Corporation
6.10.1 Danaher Corporation Corporation Information
6.10.2 Danaher Corporation Description and Business Overview
6.10.3 Danaher Corporation Cancer Biopsy Instruments and Kits Sales, Revenue and Gross Margin (2017-2022)
6.10.4 Danaher Corporation Cancer Biopsy Instruments and Kits Product Portfolio
6.10.5 Danaher Corporation Recent Developments/Updates
7 Cancer Biopsy Instruments and Kits Manufacturing Cost Analysis
7.1 Cancer Biopsy Instruments and Kits Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Cancer Biopsy Instruments and Kits
7.4 Cancer Biopsy Instruments and Kits Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Cancer Biopsy Instruments and Kits Distributors List
8.3 Cancer Biopsy Instruments and Kits Customers
9 Cancer Biopsy Instruments and Kits Market Dynamics
9.1 Cancer Biopsy Instruments and Kits Industry Trends
9.2 Cancer Biopsy Instruments and Kits Market Drivers
9.3 Cancer Biopsy Instruments and Kits Market Challenges
9.4 Cancer Biopsy Instruments and Kits Market Restraints
10 Global Market Forecast
10.1 Cancer Biopsy Instruments and Kits Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Cancer Biopsy Instruments and Kits by Type (2023-2028)
10.1.2 Global Forecasted Revenue of Cancer Biopsy Instruments and Kits by Type (2023-2028)
10.2 Cancer Biopsy Instruments and Kits Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Cancer Biopsy Instruments and Kits by Application (2023-2028)
10.2.2 Global Forecasted Revenue of Cancer Biopsy Instruments and Kits by Application (2023-2028)
10.3 Cancer Biopsy Instruments and Kits Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Cancer Biopsy Instruments and Kits by Region (2023-2028)
10.3.2 Global Forecasted Revenue of Cancer Biopsy Instruments and Kits by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
